CIK 0001124105 · Accelerated filer<br>Smaller reporting company
GYRE THERAPEUTICS, INC.
Sign in to watch- Ticker
- GYRE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 562020050
- Phone
- (858) 284-0115
- Business address
- 12730 HIGH BLUFF DRIVE, SUITE 250, SAN DIEGO, CA, 92130
- Former names
- CATALYST BIOSCIENCES, INC., TARGACEPT INC
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 8-K Event Executive or director change · Shareholder vote results
- SC 13D/A Stake Beneficial Ownership Report
- DEF 14A Proxy Proxy Statement
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- SC 13G/A Stake Amended Statement of Ownership
- 8-K Event Other events
- SC 13G Stake Amended Statement of Ownership
- SC 13G Stake Amended Statement of Ownership
- 8-K Event Material agreement · Bylaws or fiscal year change · Other events
- 424B4 Offering Prospectus
- EFFECT Other Notice of Effectiveness
- S-1MEF Other S-1MEF
- CORRESP Other Correspondence Between Filers and SEC Staff
- CORRESP Other Correspondence Between Filers and SEC Staff
- S-1/A Offering Registration Statement
- S-1/A Offering Registration Statement
Page 39 of 81 · 1,604 filings